Clinical Effectiveness of Group Cognitive Behavioral Therapy for Primary and Secondary Insomnia

團體認知行為治療對原發性及續發性失眠之臨床療效

10.29478/TJP.200909.0005

陳枻志(Yi-Chih Chen)；黃玉書(Yu-Shu Huang)；陳志根(Chih-Ken Chen)

失眠 ； 團體認知行為治療 ； 睡眠 ； 焦慮 ； insomnia ； group cognitive-behavioral therapy ； sleep ； anxiety

台灣精神醫學

23卷3期（2009 / 09 / 01）

207 - 214

英文

目的：長期睡眠問題所影響的層面不只是個人之功能表現，更會進一步造成整個健康照護體系的負擔。本研究目的，在評估團體認知行為治療於失眠病患之臨床療效。此外，我們探討原發性失眠及次發性失眠病患對團體認知行為治療的反應是否不同。方法：共收案六十位來自北臺灣某綜合醫院睡眠障礙門診之病患，參與為期六週之團體認知行為治療。每週一次，每次九十分鐘。療效評估包括睡眠日誌、曾氏焦慮量表、貝克憂鬱量表及SF-36。結果：對完成所有團體治療課程之病患（計四十一位，68.3%）而言，入睡延遲時間、曾氏焦慮量表、貝克憂鬱量表、SF-36中之活力度及一般精神健康之細項皆有顯著之改善，然而在總睡眠時間、睡眠中再清醒次數及睡眠效率上無顯著之改善。入睡延遲時間和曾氏焦慮量表評分於次發性失眠病患有顯著之改善，於原發性失眠病患則未然。結論：團體認知行為治療有效改善入睡延遲時間，而此療效對於有共病焦慮或憂鬱的失眠比對於原發性失眠顯著。

Objective: Long-term sleep problems affect personal functioning and create a burden on the health care system. The aim of this study was to evaluate the effectiveness of group cognitive-behavioral therapy (CBT) for patients with insomnia. In addition, we investigated whether patients with primary insomnia and those with secondary insomnia respond differently to group CBT. Methods: Sixty patients were recruited from the sleep disorder clinic at a general hospital in northern Taiwan. Each patient participated in a 90-minute group session once a week for 6 weeks. The assessments for efficacy included sleep diary, Zung Anxiety Scale, Beck Depression Inventory, the 36-Item Short-Form Health Survey (SF-36). Results: For those who completed the entire program (n=41, 68.3%), there were significant improvements in sleep latency, Zung Anxiety Scale, Beck Depression Inventory, and the vitality and general mental health subscales of the SF-36, but not in total sleeping time, number of awakening and sleep efficiency. Sleep latency and the score on the Zung Anxiety Scale improved significantly for those with secondary insomnia but not for those with primary insomnia. Conclusion: Group CBT is effective in improving sleep latency, and the effectiveness is more significant for insomnia with comorbid anxiety or depressive disorders than for primary insomnia.

1. American Psychiatric Association(1994).Diagnostic and Statistical Manual of Mental Disorder.Washinton, DC:American Psychiatric Association.
2. American Sleep Disorders Association(1990).International Classification of Sleep Disorder: Diagnostic and Coding Manual.Rochester, MA:American Sleep Disorders Association.
3. Backhaus J,Hohagen F,Voderholzer U,Riemann D(2001).Long-term effectiveness of a short-term cognitive-behavioral group treatment for primary insomnia.Eur Arch Psychiatry Clin Neurosci,251,35-41.
4. Beck AT,Ward CH,Mendelson M,Mock J,Erbaugh J(1961).An inventory for measuring depression.Arch Gen Psychiatry,4,561-571.
5. Edinger JD,Wohlgemuth WK(1999).The significance and management of persistent primary insomnia: the past, present and future of behavioral insomnia therapies.Sleep Med Rev,3,101-118.
6. Espie CA(1991).The psychological treatment of insomnia.Chichester, UK:J Wiley and Sons.
7. Espie CA(1999).Cognitive behaviour therapy as the treatment of choice for primary insomnia.Sleep Med Rev,3,97-99.
8. Ford DE,Kamerow DB(1989).Epidemiologic study of sleep disturbances and psychiatric disorders: An opportunity for prevention?.JAMA,262,1479-1484.
9. Hohagen F,Rink K,Kappler C(1993).Prevalence and treatment of insomnia in general practice: A longitudinal study.Eur Arch Psychiatry Clin Neurosci,242,329-336.
10. Holbrook AM,Crowther R,Lotter A,Cheng C,King D(2000).Meta-analysis of benzodiazepine use in the treatment of insomnia.Can Med Assoc J,162,225-233.
11. Hsu SC,Liu CY,Chen NH(2006).Psychiatric diagnoses of patients visiting a sleep disorder clinic due to dyssomnias.Psychol Rep,98,789-797.
12. Kales A,Soldatos CR,Bixler EO,Kales JD(1983).Rebound insomnia and rebound anxiety: a review.Pharmacology,26,121-137.
13. Lader MH(1999).Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?.Eur Neuropsychopharmacol,9(Suppl 6),399-405.
14. Leger D,Guilleminault C,Dreyfus JP,Delahaye C,Paillard M(2000).Prevalence of insomnia in a survey of 12,778 adults in France.J Sleep Res,9,35-42.
15. Morin CM(2004).Cognitive-behavioral approaches to the treatment of insomnia.J Clin Psychiatry,65(16),33-40.
16. Morin CM,Colecchi C,Stone J,Sood R,Brink D(1999).Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial.JAMA,281,991-999.
17. Morin CM,Culbert JP,Schwartz SM(1994).Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy.Am J Psychiatry,151,1172-1180.
18. Murtagh DR,Greenwood KM(1995).Identifying effective psychological treatments for insomnia: a meta-analysis.J Consult Clin Psychol,63,79-89.
19. Nomura K,Yamaoka K,Nakao M,Yano E(2005).Impact of insomnia on individual health dissatisfaction in Japan, South Korea, and Taiwan.Sleep,28,1328-1332.
20. Nowell PD,Mazumdar S,Buysse DJ,Dew MA,Reynolds CF,Kupfer DJ(1997).Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy.JAMA,278,2170-2177.
21. Ohayon MM,Caulet M,Lemoine P(1998).Comorbidity of mental and insomnia disorders in the general population.Compr Psychiatry,39,185-197.
22. Ohayon MM,Partinen M(2002).Insomnia and global sleep dissatisfaction in Finland.J Sleep Res,11,339-346.
23. Pallesen S,Nordhus IH,Nielsen GH(2001).Prevalence of insomnia in the adult Norwegian population.Sleep,24,771-779.
24. Ware JE,Sherbourne CD(1992).The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.Med Care,30,473-483.
25. Yang CM,Spielman AJ,Huang YS(2005).Insomnia.Curr Treat Options Neurol,7,373-386.
26. Zung WW(1971).A rating instrument for anxiety disorders.Psychosomatics,12,371-379.

1. 廖御圻,詹雅雯,楊建銘,郭乃文,許文耀,姜忠信,花茂棽,林耀盛,林宜美,吳英璋,王韋婷(2019)。科學家與實務者：台灣臨床心理學的共時性顧後瞻前。中華心理學刊，61(4)，361-392。